全文获取类型
收费全文 | 20007篇 |
免费 | 1948篇 |
国内免费 | 305篇 |
专业分类
耳鼻咽喉 | 212篇 |
儿科学 | 635篇 |
妇产科学 | 353篇 |
基础医学 | 1817篇 |
口腔科学 | 149篇 |
临床医学 | 2431篇 |
内科学 | 3310篇 |
皮肤病学 | 354篇 |
神经病学 | 3333篇 |
特种医学 | 362篇 |
外科学 | 1930篇 |
综合类 | 2364篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 1853篇 |
眼科学 | 142篇 |
药学 | 1441篇 |
29篇 | |
中国医学 | 759篇 |
肿瘤学 | 784篇 |
出版年
2024年 | 50篇 |
2023年 | 427篇 |
2022年 | 564篇 |
2021年 | 993篇 |
2020年 | 1084篇 |
2019年 | 986篇 |
2018年 | 906篇 |
2017年 | 967篇 |
2016年 | 933篇 |
2015年 | 826篇 |
2014年 | 1405篇 |
2013年 | 1775篇 |
2012年 | 1147篇 |
2011年 | 1238篇 |
2010年 | 935篇 |
2009年 | 938篇 |
2008年 | 1023篇 |
2007年 | 968篇 |
2006年 | 742篇 |
2005年 | 648篇 |
2004年 | 518篇 |
2003年 | 433篇 |
2002年 | 341篇 |
2001年 | 279篇 |
2000年 | 233篇 |
1999年 | 194篇 |
1998年 | 168篇 |
1997年 | 165篇 |
1996年 | 147篇 |
1995年 | 142篇 |
1994年 | 112篇 |
1993年 | 96篇 |
1992年 | 105篇 |
1991年 | 93篇 |
1990年 | 92篇 |
1989年 | 70篇 |
1988年 | 70篇 |
1987年 | 55篇 |
1986年 | 46篇 |
1985年 | 60篇 |
1984年 | 44篇 |
1983年 | 31篇 |
1982年 | 47篇 |
1981年 | 40篇 |
1980年 | 24篇 |
1979年 | 23篇 |
1978年 | 18篇 |
1977年 | 22篇 |
1975年 | 10篇 |
1974年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
2019年12月始,新型冠状病毒肺炎(Corona Virus Disease 2019,COVID-19)以湖北武汉为中心向全国各地蔓延。目前数据显示,COVID-19合并糖尿病、高血压、肿瘤等基础病的患者病情较为严峻,病死率相对较高。该类患者的临床治疗策略有待进一步深入研究。在此次疫情防治过程中,中西医结合治疗手段于COVID-19的防治及患者基础疾病的兼顾治疗方面展现出了一定的特色及优势。本文结合中医“未病先防,既病防变,瘥后防复”思想,拟从COVID-19合并糖尿病、高血压、肿瘤三个方面,探讨COVID-19爆发形势下合并基础病患者的中医药防治策略。 相似文献
22.
目的:分析鼻塞式同步间歇正压通气(NIPPV)联合布地奈德雾化治疗ARDS(新生儿急性呼吸窘迫综合征)疾病的临床应用效果。方法:纳入病例是2017年5月—2019年11月收治的104例ARDS新生儿,随机平均分为两组。参照组52例采纳CPAP(持续气道正压通气通气)治疗,实验组52例采纳NIPPV+布地奈德雾化治疗,对比两组呼吸机通气时间、用氧时间、住院时间、血气指标以及并发症发生情况。结果:实验组呼吸机通气时间、用氧时间、住院时间均明显短于参照组,差异有统计学意义P<0.05;实验组治疗3 d后PaCO2明显低于参照组,实验组治疗3 d后PH以及PaO2明显高于参照组,差异有统计学意义P<0.05;实验组并发症发生率(3.85%,2/52)明显低于参照组(21.15%,11/52),差异有统计学意义P<0.05。结论:NIPPV+布地奈德雾化可有效缩短ARDS患者机械通气时间,改善血气指标,降低并发症发生率,值得借鉴。 相似文献
23.
24.
25.
Fur-Hsing Wen Jen-Shi Chen Wen-Chi Chou Wen-Cheng Chang Wen Chi Shen Chia-Hsun Hsieh Siew Tzuh Tang 《Journal of pain and symptom management》2019,57(1):64-72
Context
Family caregivers constitute a critical component of the end-of-life care system with considerable cost to themselves. However, the joint association of terminally ill cancer patients' symptom distress and functional impairment with caregivers' subjective caregiving burden, quality of life (QOL), and depressive symptoms remains unknown.Objectives/Methods
We used multivariate hierarchical linear modeling to simultaneously evaluate associations between five distinct patterns of conjoint symptom distress and functional impairment (symptom-functional states) and subjective caregiving burden, QOL, and depressive symptoms in a convenience sample of 215 family caregiver–patient dyads. Data were collected every 2 to 4 weeks over patients' last 6 months.Results
Caregivers of patients in the worst symptom-functional states (States 3–5) reported worse subjective caregiving burden and depressive symptoms than those in the best two states, but the three outcomes did not differ between caregivers of patients in State 3 and States 4–5. Caregivers of patients in State 5 endured worse subjective caregiving burden and QOL than those in State 4. Caregivers of patients in State 4 suffered worse subjective caregiving burden and depressive symptoms but comparable QOL to those in State 2.Conclusion
Patients' five distinct, conjoint symptom-functional states were significantly and differentially associated with their caregivers' worse subjective caregiving burden, QOL, and depressive symptoms while caring for patients over their last 6 months. 相似文献26.
27.
28.
29.
30.
《Drug metabolism and pharmacokinetics》2019,34(5):308-316
LC-MS quantification of drug metabolites is sometimes impeded by the availability of internal standards that often requires customized synthesis and/or extensive purification. Although isotopically labeled internal standards are considered ideal for LC-MS/MS based quantification, de novo synthesis using costly isotope-enriched starting materials makes it impractical for early stage of drug discovery. Therefore, quick access to these isotope-enriched compounds without chemical derivatization and purification will greatly facilitate LC-MS/MS based quantification. Herein, we report a novel 18O-labeling technique using metabolizing enzyme carboxylesterase (CES) and its potential application in metabolites quantification study. Substrates of CES typically undergo a two-step oxygen exchange with H218O in the presence of the enzyme, generating singly- and doubly-18O-labeled carboxylic acids; however, unexpected hydrolytic behavior was observed for three of the test compounds – indomethacin, piperacillin and clopidogrel. These unusual observations led to the discovery of several novel hydrolytic mechanisms. Finally, when used as internal standard for LC-MS/MS based quantification, these in situ labeled compounds generated accurate quantitation comparable to the conventional standard curve method. The preliminary results suggest that this method has potential to eliminate laborious chemical synthesis of isotope-labeled internal standards for carboxylic acid-containing compounds, and can be developed to facilitate quantitative analysis in early-stage drug discovery. 相似文献